Your Interview Prep Edge: UCL Spotlight, Hepatitis Analysis & This Week's Medical Breakthroughs

Alzheimer's blood test shows predictive promise

Research published this month in Nature Medicine demonstrates that a blood-based circular RNA signature can accurately detect Alzheimer's disease and even predict symptom onset before clinical manifestation. This less invasive diagnostic approach could enable earlier detection and improved monitoring compared with current biomarkers, offering significant implications for patient care and treatment timing.

NHS approves landmark cancer drugs for rare blood cancers

NHS England announced in July 2026 that new cancer treatments for children and adults with rare blood cancers will now be available following Clinical Priorities Advisory Group approval. The rollout includes therapies for histiocytosis and follicular lymphoma, offering hope to hundreds of patients who have exhausted other treatment options. One patient described her access to dabrafenib as life-changing, avoiding the need for a stem cell transplant.

AI tools to save NHS staff two days per month

NHS England confirmed in June 2026 that over 500,000 NHS staff will receive access to Microsoft 365 Copilot, an AI administrative assistant. Following the largest AI healthcare trial globally, results showed that AI-powered support could save an average of 43 minutes per staff member per day—equivalent to five weeks annually. The initiative forms part of the NHS 10 Year Health Plan to boost productivity and redirect clinical time toward patient care.

T-cell therapy achieves remission in paediatric cancer

A report in the New England Journal of Medicine documented a child with advanced nephroblastoma who achieved a 69% tumour reduction following T-cell therapy targeting preferentially expressed antigen in melanoma. Molecular, metabolic and histologic evidence confirmed complete remission at 200 days, highlighting the therapeutic potential of personalised cell-based treatments in paediatric oncology.

These developments underscore the pace of innovation reshaping diagnosis, treatment and workforce efficiency—all themes you may encounter in interviews or ethical discussions this season. Stay informed and ready to reflect critically on how medical advances translate into real-world care.

World Hepatitis Day 2026 carried the theme "Hepatitis: Let's break it down"—a call to dismantle barriers preventing access to testing, treatment and care. While the slogan is compelling, it invites scrutiny of what "breaking down" actually requires beyond rhetoric.

The paradox of available tools and persistent gaps

The WHO emphasises that effective vaccines, accurate diagnostics and curative treatments for hepatitis C already exist, alongside lifelong therapies for hepatitis B. Yet millions remain undiagnosed or untreated due to stigma, limited awareness, health-system fragmentation and inequalities. This paradox—that the tools exist but the outcomes lag—highlights a disconnect between what works and who benefits.

In the UK context, NHS England reported in August 2025 that over 100,000 people had been tested for hepatitis C through its confidential home testing service. That's progress, but it also reveals a dependency on patient-initiated engagement. If awareness remains low and stigma high, how many at-risk individuals never seek testing in the first place?

What does "breaking down barriers" mean in practice?

The 2026 campaign lists barriers including cost, stigma, and unequal access. But these categories can obscure complexity. For instance:

• Stigma is not monolithic. It manifests differently across communities and intersects with ethnicity, substance use, sexual orientation and immigration status. Addressing it requires culturally tailored interventions, not generic messaging.
• Health-system integration sounds efficient, but integrating hepatitis care into primary care and universal health coverage systems demands workforce training, resource allocation and sustained funding—none of which campaigns directly deliver.
• Political commitment is repeatedly invoked. Yet commitment without accountability mechanisms risks becoming performative.

A regional lens: progress and persistence

WHO data show that the European Region has surpassed the hepatitis B elimination target among children under 5, with prevalence at 0.06%. New hepatitis C infections have declined by 28% since 2015. These are genuine wins. Yet 9.7 million people live with hepatitis B and 5.6 million with hepatitis C across the region. Only 23% of people with hepatitis B have been diagnosed, and just 4.2% receive treatment.

This tells us that awareness days can spotlight issues, but changing population-level outcomes requires systems change. Egypt's move from one of the world's highest hepatitis C burdens to "gold tier" elimination status was driven by coordinated government action, sustained investment and mass screening—not a single campaign.

Critical questions for applicants

As you prepare for interviews, consider:

• How do we reconcile the availability of effective interventions with persistent inequities in access?
• What role do healthcare professionals play in reducing stigma—and where might medical culture inadvertently reinforce it?
• When political commitment is cited as essential, what does meaningful accountability look like?

World Hepatitis Day 2026 rightly calls for action. The challenge is ensuring that calls translate into measurable, sustained change rather than annual reminders of unmet potential.

The NHS's recent approval of new cancer drugs for rare blood cancers and the rollout of gene therapies across multiple conditions raises a question that sits at the heart of healthcare ethics: when resources are finite, how do we decide which treatments to fund—and for whom?

This is not a theoretical dilemma. NHS England's Clinical Priorities Advisory Group evaluates dozens of specialist medicines, devices and treatments each year according to patient benefit, clinical effectiveness and value for money. Each approval represents a trade-off: funding one high-cost therapy may mean deferring investment elsewhere.

The QALY question

The National Institute for Health and Care Excellence (NICE) uses cost-effectiveness thresholds, often expressed in Quality-Adjusted Life Years (QALYs), to guide funding decisions. A treatment is typically deemed cost-effective if it costs less than £20,000–£30,000 per QALY gained. But this framework has limitations:

• Rare diseases and small patient populations can skew cost-per-QALY calculations, making individually life-saving treatments appear economically unviable.
• End-of-life therapies receive higher thresholds, acknowledging societal willingness to pay more for treatments that extend life in terminal illness.
• Equity considerations are harder to quantify. Should we prioritise treatments that benefit the greatest number, or ensure those with rare conditions are not disadvantaged?

Ethical frameworks in tension

Utilitarianism would argue for maximising overall health gain across the population—favouring treatments with broad applicability and proven cost-effectiveness.

Egalitarianism emphasises equal access and fair distribution, suggesting that patients with rare or complex conditions deserve the same consideration as those with common diseases.

The rule of rescue captures the instinct to prioritise identifiable individuals in immediate need—often the driver behind compassionate access programmes and high-profile campaigns.

These principles can conflict. A treatment costing £500,000 per patient might save one child's life but could alternatively fund hip replacements for fifty adults or mental health services for hundreds. How do we weigh these outcomes?

Discussion points for interviews

• Transparency vs trust: Should the NHS publicly disclose the economic calculations behind treatment approvals, or does transparency risk undermining public trust in rationing decisions?
• Innovation and precedent: Approving one high-cost gene therapy may set a precedent that makes it harder to decline future therapies. Is this a valid concern, or does it unfairly penalise patients who could benefit now?
• Patient voice: Families of patients with rare diseases often advocate passionately for access. How should clinicians and policymakers balance these voices with population-level health needs?
• Global context: The NHS is among the world's most equitable healthcare systems. In countries without universal coverage, these dilemmas are magnified. What responsibilities do wealthier health systems have internationally?

Where do you stand?

There is no single "correct" answer. Interviewers are looking for your ability to recognise complexity, articulate multiple perspectives, and reason through trade-offs with empathy and logic. Avoid oversimplified positions ("we should fund everything" or "only cost-effective treatments matter"). Instead, demonstrate nuanced thinking that acknowledges values, evidence and real-world constraints.

Resource allocation is one of the hardest ethical challenges in modern medicine—and one you'll face throughout your career.

You've probably heard that "reflection" matters in medical school interviews. But what does good reflection actually look like—and how do you move beyond surface-level answers to responses that genuinely stand out?

Many applicants describe what they did during work experience. Fewer explain what they learned. Even fewer demonstrate how that learning has changed their understanding or behaviour. That third level—evidence of insight translated into action—is what interviewers are listening for.

The three-layer model

Layer 1: Description – "I shadowed a GP for two weeks and observed consultations."

Layer 2: Observation – "I noticed how much time the GP spent listening, not just diagnosing. One patient came in with back pain but spent most of the consultation talking about isolation after his wife's death."

Layer 3: Insight and application – "It challenged my assumption that consultations are primarily about clinical problem-solving. I've since volunteered with a befriending service for older adults, which has deepened my understanding of how loneliness shapes health. It's made me more attentive to what patients aren't saying."

Layer 3 is where competitive applicants live. It shows self-awareness, initiative and the ability to connect experiences across contexts.

Common pitfall: retrofitting learning

When asked, "What did you learn from your work experience?" many applicants list generic skills: communication, teamwork, empathy. These aren't wrong, but they lack specificity. Interviewers can tell when you're reaching for what you think they want to hear rather than describing genuine moments of growth.

Instead, anchor your answer in a specific moment. What surprised you? What made you uncomfortable? What assumption did you revise? These are the raw materials of authentic reflection.

The "so what?" test

After every reflective statement, ask yourself: so what? If you say, "I learned that communication is important," the interviewer is thinking, "So what—everyone knows that." But if you say, "I realised that the way a doctor frames risk can completely change a patient's decision, and I've been reading about shared decision-making frameworks to understand how to do that well," you've moved from observation to active learning.

Practical strategies

Keep a reflection journal during work experience and volunteering. Write down one specific moment each day that challenged or surprised you. When interview prep begins, you'll have a bank of concrete examples rather than vague memories.

Use the STARR model (Situation, Task, Action, Result, Reflection). The final R is what most applicants skip. Don't just describe the outcome—explain what you took away and how it influenced you afterward.

Prepare follow-up responses. If you mention an experience, assume the interviewer will ask, "And what did that teach you?" or "How has that shaped your view of medicine?" Have your second-level answer ready.

Avoid the humility trap. Some applicants downplay their experiences ("It was only a week, so I didn't learn that much"). Interviewers aren't assessing the length of your placement—they're assessing your capacity to learn from it. A single well-reflected afternoon can be more impressive than a month of superficial observation.

School-specific note: UCL

UCL explicitly values reflection over volume of experience. Their interviewers frequently ask, "Tell me about a time your assumptions were challenged" or "Describe a situation where you received critical feedback—how did you respond?" They're testing whether you can move beyond rehearsed narratives to genuine self-awareness. Two deeply reflected placements will outperform five surface-level ones every time.

For tailored guidance on structuring reflective answers and practising under timed conditions, explore our Interview Preparation resources.

Bottom line

Reflection isn't about sounding thoughtful—it's about being thoughtful. Interviewers can distinguish between students who've been coached to say the right things and those who've genuinely engaged with their experiences. The latter group doesn't just get offers. They become better doctors.

Interview season is here. If you've been shortlisted, you've already cleared the academic threshold—now it's about preparation, clarity and composure on the day. Here are three high-impact actions you can take this week.

1. Audit your personal statement for interview traps

Your interviewers will have read your personal statement. Every claim you've made is fair game for questioning. Before your interview, re-read your statement with a critical eye and ask:

• Can I elaborate on every experience I mentioned with specific examples?
• Are there any phrases I used because they sounded good, but I can't actually defend? (e.g., "I was inspired by the multidisciplinary team"—which team members, doing what, and why did it matter?)
• Have I mentioned books, papers or concepts I'd struggle to discuss in detail?

Mark up your statement with bullet-point notes for each claim. Practise talking through them aloud. If something feels shaky, either prepare a solid answer or be ready to admit the limits of your knowledge honestly ("I observed the team briefly, but I'd like to learn more about how roles are coordinated").

2. Prepare one current healthcare topic in depth

Many interviews include a question about NHS challenges, recent medical news or health policy. Don't try to memorise ten topics superficially—pick one you genuinely find interesting and go deep.

Good current options for August 2026 interviews:

• AI in the NHS: the rollout of Microsoft Copilot to 500,000 staff, balancing efficiency gains with concerns about data security and clinical oversight.
• Health inequalities: how the NHS 10 Year Health Plan aims to target funding to areas with disproportionate economic and health challenges.
• Gene and cell therapies: recent NHS approvals for rare cancers and the ethical/economic questions around high-cost, low-volume treatments.

For your chosen topic, know:

• The key facts (what, when, who)
• Multiple perspectives (benefits, risks, ethical considerations)
• Your own reasoned view (not just restating others' opinions)

This depth signals intellectual curiosity and the ability to engage critically—not just recite headlines.

3. Simulate the pressure with timed mock answers

Knowing what to say is different from saying it clearly under pressure. Set a timer for 90 seconds and practise answering common questions aloud:

• Why medicine?
• Tell me about a time you worked in a team.
• What challenges does the NHS face?
• Describe a situation where you received criticism.

Record yourself (audio is fine) and listen back. Are you rambling? Repeating filler words? Taking too long to get to the point? Most applicants underestimate how much tighter their answers need to be.

If possible, ask a teacher, friend or family member to fire questions at you with no advance warning. The discomfort of not knowing what's coming is exactly what you need to practise managing.

For structured mock interview practice and model answers tailored to your target schools, check out NextGenMedPrep's Interview Preparation.

Bonus: logistical check

Confirm your interview details now—date, time, format (in-person or online), location and any tech requirements. If online, test your camera, microphone and internet connection in advance. If in-person, plan your journey with a 30-minute buffer. These basics sound obvious, but last-minute tech failure or a missed train can derail even the best-prepared candidate.

You've worked hard to get this far. These three actions will help you walk in confident, composed and ready to perform at your best.

UCL Medical School sits in the heart of London, consistently ranking among the most competitive UK medical schools. Its six-year MBBS programme includes a mandatory integrated BSc (iBSc) in year three, blending scientific depth with early clinical exposure. If you're considering UCL, here's what you need to know.

Entry requirements

A-Levels: AAA, including Chemistry and Biology (or Chemistry and one other science). UK graduates holding a degree are exempt from the iBSc and complete the course in five years.

GCSEs: Evidence of sustained academic achievement with broad study of Science, English and Maths up to age 16. While UCL doesn't publish a specific grade threshold, most successful applicants present strong GCSE profiles.

UCAT: UCL uses total UCAT cognitive subtest scores (VR + DM + QR + AR; maximum 2,700) for interview shortlisting. The Situational Judgement Test (SJT) is used only as a tiebreaker. Recent offer holders have averaged scores around 2,500+; candidates below approximately 2,400 are rarely interviewed. Check TrueScore for the most up-to-date UCAT predictions specific to UCL.

Personal statement: UCL does not use the personal statement to select candidates for interview. However, interviewers read it beforehand and use it to generate follow-up questions. Every claim you make must be defensible in person.

The iBSc: a defining feature

UCL's integrated BSc in year three is compulsory for students without prior UK degrees. You choose from a range of scientific, clinical or population health topics and complete an extended research project. This year out gives you space to develop research skills, pursue academic interests and return to clinical years with a deeper scientific foundation.

For applicants, this signals UCL's commitment to producing clinicians who are scientifically literate and research-engaged. Be ready to discuss why the iBSc appeals to you—or at least why you're comfortable with it.

Interview format

UCL uses a single panel interview lasting approximately 15–20 minutes, with 2–3 interviewers (often a clinician, an academic and a senior student). This is one of the more conversational interview formats in the UK. Expect:

• Motivation and reflection: Why medicine? Why UCL? What have you learned from work experience?
• Ethics: Typically one scenario testing your ability to reason through dilemmas using frameworks like the four pillars (autonomy, beneficence, non-maleficence, justice).
• Current affairs or data interpretation: You may be asked to comment on a healthcare issue or interpret a short data table/graph.
• Personal statement exploration: Interviewers will probe specific experiences. Expect questions like, "Tell me about a time you received critical feedback" or "What surprised you most during your volunteering?"

UCL famously weights communication and reflection above scientific knowledge. The interview is a discussion, not a viva, and rarely tests A-Level science directly. Authenticity and self-awareness matter more than polished answers.

For detailed question breakdowns and model responses, see NextGenMedPrep's UCL Interview Guide.

Clinical placements

UCL students train across major London teaching hospitals, including University College Hospital (UCLH), the Royal Free, the Whittington and Great Ormond Street. This breadth of placements exposes you to diverse patient populations, specialist services and cutting-edge research environments. Central London also offers unparalleled access to museums, libraries and extracurricular opportunities.

Widening participation

Access UCL is the contextual offer scheme for applicants from underrepresented backgrounds. Eligible students automatically receive a reduced offer of AAB (with AA in Biology and Chemistry). Eligibility is based on POLAR quintile, school type, free school meals history and household income. Most applicants' eligibility is picked up automatically from their UCAS application.

Target Medicine is UCL's widening participation initiative, offering a mentoring scheme, summer school and summer challenge for students from backgrounds underrepresented in medicine.

What UCL is looking for

UCL's goal is to educate "The UCL Doctor": a highly capable, patient-centred clinician equipped to practise medicine in a professional, inclusive and sustainable way grounded in science and best practice. In interviews, they're assessing whether you'll thrive in their integrated, research-focused curriculum and contribute meaningfully to a diverse cohort.

Key attributes:

• Intellectual curiosity: Are you excited by the iBSc model? Can you discuss scientific or clinical topics with depth?
• Reflective capacity: Have you learned from your experiences, or simply accumulated them?
• Communication: Can you explain complex ideas clearly and listen actively?
• Ethical reasoning: Can you navigate dilemmas with nuance, balancing principles and real-world constraints?

Application timeline

UCL interviews take place between early December and late February, typically in person at the central London campus (though international applicants may be offered online interviews). Decisions are released on a fixed date in mid-March each year via UCAS Hub—UCL does not release offers on a rolling basis.

How competitive is UCL?

Very. UCL receives a high volume of applications for limited places and does not make offers to all academically eligible applicants. UCAT scores are critical for shortlisting, and interview performance heavily influences final decisions. Most successful applicants present Cambridge-tier UCAT scores alongside strong predicted grades and well-reflected work experience.

For strategic advice on school selection and maximising your chances across your UCAS choices, explore NextGenMedPrep's Application Strategy service.

Final thought

UCL rewards depth over breadth—in academic curiosity, reflective capacity and communication. If you're drawn to a research-rich environment in central London and you're comfortable with a mandatory BSc year, UCL may be an excellent fit. Prepare thoroughly, know the school's unique features inside out, and bring your authentic self to the interview.

NextGenMedPrep TrueScore for University College London (UCL): ~2150/2700 — the UCAT score we predict you'll need to reach interview (2027 entry). See all predictions and check our Medical School Rankings.